Navigation Links
Hanger Orthopedic Group, Inc. Announces Pricing of $200 Million of Senior Notes
Date:10/20/2010

AUSTIN, Texas, Oct. 20 /PRNewswire-FirstCall/ -- Hanger Orthopedic Group, Inc. (NYSE: HGR) today announced that it priced $200 million of senior notes due 2018 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933 and in offshore transactions pursuant to Regulation S under the Securities Act.  The notes were priced at par with an interest rate of 7 1/8%. The offering is expected to close on November 2, 2010.

The notes have not been registered under the Securities Act of 1933 or the securities laws of any state and may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act and applicable state securities laws.  This press release does not constitute an offer to sell or the solicitation of an offer to buy the notes, nor shall there be any sale of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

About Hanger Orthopedic Group, Inc.

Hanger Orthopedic Group, Inc., headquartered in Austin, Texas, is the world's premier provider of orthotic and prosthetic patient care services. Hanger is the market leader in the United States, owning and operating in excess of 675 patient care centers in 45 states and the District of Columbia, with more than 3,800 employees, including over 1,100 practitioners, as of September 30, 2010.  Hanger is organized into four units. The two key operating units are patient care, which consists of nationwide orthotic and prosthetic practice centers, and distribution, which consists of distribution centers managing the supply chain of orthotic and prosthetic componentry to Hanger and third party patient care centers. The third is Linkia, which i
'/>"/>

SOURCE Hanger Orthopedic Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hanger Orthopedic Group Signs Definitive Merger Agreement To Acquire Accelerated Care Plus
2. Hanger Orthopedic Group Announces Preliminary Third Quarter Revenue and Earnings
3. FDAs Just Approved Monthly Drug Treatment, Vivitrol Could Be Game Changer, Says Countrys Largest Drug Treatment Recovery President, CRCs Jerry Rhodes; Provides Addicts One Decision A Month Instead of 30
4. Hanger Orthopedic Group, Inc. Announces Third Quarter 2010 Earnings Release Conference Call
5. Hanger Orthopedic Group, Inc. Announces Second Quarter 2010 Earnings Release Conference Call
6. Hanger Ivan R. Sabel Foundation to Receive $75,000 Donation Towards Charitable Prosthetic Efforts in Haiti from Grapes for Humanity/US
7. Hanger Orthopedic Group Honored for its Charitable Relief Efforts in Haiti by InterAction
8. Hanger Orthopedic Group, Inc. Announces Three Acquisitions With Annual Revenues of $14.0 Million
9. Hanger Orthopedic Group, Inc. Reports an Increase of 42.3% in Earnings Per Share, to $0.37 on a 10.6% Sales Increase, for the Fourth Quarter 2009
10. Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call
11. Hanger Orthopedic Group Increases Q4 2009 Sales and EPS Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Premune and Innovet ... licensing agreement for Redonyl ® Ultra. The product, ... veterinary dermatology market, is a nutritional supplement based on ... in dogs and cats. Redonyl ® Ultra is ... has been received positively in the country by veterinarians ...
(Date:8/31/2015)... PLEASANTON, Calif. , Aug. 31, 2015  QT Vascular ... "QT Vascular", and together with its subsidiaries, the ... assembly and distribution of advanced therapeutic solutions for ... today the final results of the below-the-knee ("BTK") ... Registry ("BAR") which were presented on August 15, ...
(Date:8/31/2015)... Aug. 31, 2015   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade cell ... cryopreservation freeze media and a related ... for smart shippers ("BioLife" or the ... an advanced biopharmaceutical company focused on developing and ...
Breaking Medicine Technology:Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
... BOSTON, April 4, 2011 PAREXEL International Corporation (NASDAQ: ... financial results on Monday, May 2, 2011 after the close ... PAREXEL,s website at www.PAREXEL.com and on the PR ... host a conference call and live webcast at 10:00 a.m. ...
... CITY, Calif., April 4, 2011 Sofie Biosciences, a ... launch of GENISYS4, their new benchtop small animal PET ... Cancer Research Annual Meeting, this compact, preclinical multimodality PET ... and measure the biology of disease and therapeutic response ...
Cached Medicine Technology:PAREXEL Announces Date of Third Quarter Fiscal Year 2011 Earnings Release and Conference Call 2Sofie Biosciences Launches a High Performance, Benchtop Preclinical PET System Using New Generation Detector Technology 2
(Date:9/1/2015)... ... 01, 2015 , ... Éminence Organic Skin Care is adding ... Peels. This revolutionary collection of natural peel solutions complements the existing routine for ... Formulated with alpha hydroxy acids and natural active ingredients, these results-oriented peels deliver ...
(Date:9/1/2015)... , ... September 01, 2015 , ... Dr. Trace Curry ... JourneyLite of Cincinnati. In the last month the FDA has approved two intra-gastric ... ™. These procedures represent the first incisionless, reversible, weight loss procedures available to ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... archiving solution integrated with Alfresco‘s enterprise content management system. PRO Archiver for ... millions of dollars in printing costs by digitizing vast amounts of customer ...
(Date:9/1/2015)... Pasadena, California (PRWEB) , ... September 01, 2015 ... ... Anna Arrowsmith interviewed dating men and pick-up artists about their experiences of female ... alongside men’s bodily concerns, including penis issues, as well as their relationships with ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Anthony J. ... the Super Lawyers 2015 for his third consecutive year in a row. Through ... accomplishments of helping people. , Born in Niagara Falls, New York, Tantillo is a ...
Breaking Medicine News(10 mins):Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 3Health News:Female Porn Director Explains Male Insecurities about Women in a New Book 2
... test is all it could take to tell if you ... team of international scientists have discovered more than 10 types ... of a person who recently suffered a stroke or heart ... international collaboration led by Nanyang Technological University (NTU),s lead scientist, ...
... Virginia G. Piper Cancer Center Clinical Trials are the first ... determine the safety, tolerability and preliminary activity of an investigational ... form of lung cancer, as well as other forms of ... patient on the study was administered the first dose of ...
... in infant death are significantly more likely to have ... September) in BJOG: An International Journal of Obstetrics ... rates of stillbirth in subsequent pregnancy, the study by ... the University of Rochester found. Infant mortality ...
... News) -- People who are depressed are at greater risk ... researchers pointed out that the findings could have a significant ... of death and permanent disability. Researchers analyzed 28 previous ... 8,478 stroke cases. The investigators found that depression was associated ...
... Scientists proposing to develop vaccines against methamphetamine and nicotine ... for Innovative Medication Development Research. The two scientists, ... and Dr. Peter Burkhard, of the University of Connecticut, ... years to support their research, according to the National ...
... , TUESDAY, Sept. 20 (HealthDay News) -- Black women who develop ... second cancer in the other breast, and those who are diagnosed ... cancer of a more aggressive form, new research indicates. ... to be more aggressive, more likely to be estrogen-receptor negative and ...
Cached Medicine News:Health News:Novel research set to pinpoint risk of heart attacks and strokes 2Health News:Novel research set to pinpoint risk of heart attacks and strokes 3Health News:TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer 2Health News:Infant mortality linked to subsequent risk of stillbirth finds new US study 2Health News:Infant mortality linked to subsequent risk of stillbirth finds new US study 3Health News:Depression Tied to Higher Risk for Stroke 2Health News:NIDA Avant-Garde-Medications Development Award winners announced 2Health News:Higher Risk of Second Breast Cancer Seen in Black Women 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: